MyAverix Finance
AU · Healthcare
Dimerix Ltd (DXB)
Biotechnology
Dimerix Ltd (DXB) is listed on AU in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for DXB
P/E ratio
25.00
Dimerix Ltd (DXB) — FAQ
What is DXB's P/E ratio?
The price-to-earnings (P/E) ratio for Dimerix Ltd (DXB) is 25.00 (data as of 2026-05-24).
Does Dimerix Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Dimerix Ltd (DXB). Check the MyAverix Finance app for the latest dividend data.
What sector is Dimerix Ltd in?
Dimerix Ltd (DXB) is classified in the Healthcare sector (Biotechnology industry).
What exchange is DXB listed on?
DXB is listed on AU.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.